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Abstract  
This review describes botanical, chemical, pharmacological and phytotechnological properties of Passiflora alata Curtis, with emphasis on analytical 
methods. Native to Brazil, P. alata is featured in several pharmaceutical preparations registered by the regulatory agency ANVISA. In four of the five 
editions of the Brazilian Pharmacopoeia, P. alata leaves have been included under the designation of “maracujá” or “maracujá doce” (sweet passion fruit). 
This species is cited as Passiflora alata Curtis and was originally published in 1788 in the Botanical Magazine. In the last decade, phytochemical and 
pharmacological studies of Brazilian researchers related to this plant have increased. Despite several studies, the substances responsible for the anxiolytic, 
sedative, antioxidative and antiulcer activities attributed to passifloras remain unknown. Analytical methods for the quantification of markers are being 
developed in order to improve quality control analysis and to better understand the relationship between chemical markers and their pharmacological effects. 
Those methods include spectrophotometry, high performance thin-layer chromatography (HPTLC) and high performance liquid chromatography (HPLC). 
There is also great interest in the technological processes involved in the production of dry extracts of this native medicinal plant with the primary goal of 
assuring the quality of phytopharmaceutical products.  
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Resumen 
En esta revisión se describen las caracteristicas botánicas, químicas, farmacológicas y fitotecnologicas de Passiflora alata Curtis, con enfasis en los métodos 
analíticos. Originaria de Brasil, varias preparaciones farmacéuticas de P. alata son registradas por el organismo regulador ANVISA. En tres de las cinco 
ediciones de la Farmacopea Brasileña, las hojas de P. alata se han incluido bajo la denominación de "maracuyá" (fruta de la pasión). Esta espécie deve ser 
citada como Passiflora alata Curtis, publicada originalmente en 1788 en “Botanical Magazine”. En la última década, los estudios fitoquímicos y 
farmacológicos de investigadores brasileños relacionados con esta planta han aumentado substancialmente. A pesar de varios estudios, las sustancias 
responsables de las actividades ansiolítica, sedante, antioxidante y antiulcerosa atribuidas a la passiflora continuan siendo desconocidos. Los métodos 
analíticos para la cuantificación de los marcadores están siendo desarrollados con el fin de mejorar el análisis de control de calidad y para comprender mejor 
la relación entre marcadores químicos y sus efectos farmacológicos. Estos métodos incluyen espectrometría de alto rendimiento, cromatografía en capa fina 
(HPTLC) y la cromatografía líquida de alta resolución (HPLC). También existe un gran interés en los procesos tecnológicos envueltos en la producción de 
extractos secos con el objetivo principal de asegurar la calidad de los productos fitosanitarios. 
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1. INTRODUCTION 
The use of natural products, especially those derived 
from plants, is one of the oldest forms of medical 
treatment for sickness and injury. Scientific interest in 
herbal drugs has increased considerably during the last 
ten years, and efforts have been made to understand 
the basis of the medicinal properties of plants 
(Newman et al., 2003; Mahmmoud, 2007). 
The Passifloraceae family is distinguished 
from other plants used in Brazilian folk medicine due 
to its extensive use in the treatment of a wide variety 
of diseases. The Passiflora genus comprises about 400 
species and is the most important genus of this family. 
Passifloraceae is represented by approxima-tely 23 
genera and 600 species distributed mainly in tropical 
and subtropical regions, many of them in Brazil. There 
are four genera with about 80 species and a wide 
geographical distribution that are native to Brazil. 
Most of these species related to the Passiflora, and 
products derived from these plants are internationally 
recognized as herbal medicines (Carlini, 2003).  
The most well-known species of this family is 
Passiflora incarnata L., found in Europe and North 
America. It is included in the pharmacopoeia of most 
countries, as well as the British Herbal (British Herbal 
Pharmacopeia, 1996), French (Pharmacopée 
Francaise, 1992) and European (European 
Pharmacopeia, 2007) pharmacopoeias. In Brazil, 
species of the Passiflora are known as “maracujá” 
(passion fruit). P. alata and P. edulis are the only 
passion fruit species currently cultivated on a 
commercial scale.  They are mainly produced in Sao 
Paulo State and their fruit is consumed in natura or in 
juices and ice creams (Souza and Meletti, 1997). 
P. alata, originally published in 1788 in the 
Botanical Magazine (Curtis, 1770, Bernacci et al., 
2003; Trópicos, 2010), is native to Brazil and is used 
in several pharmaceutical preparations that are 
registered by the regulatory agency ANVISA 
“Agência Nacional de Vigilância Sanitária” 
(Nascimento et al., 2005; Carvalho et al., 2008; Brasil, 
2011). In three of the five editions of the Brazilian 
Pharmacopeia (Silva, 1929; Farmacopeia dos Estados 
Unidos do Brasil, 1959; Farmacopéia Brasileira, 1977; 
Brandão et al., 2009) its leaves have been designated 
as “maracujá” and the fifth edition it is cited as 
“maracujá doce” (Brasil, 2010).  
In the last decade, the number of 
phytochemical and pharmacological studies related to 
this vegetal species has increased. One of the 
pioneering phytochemical studies with P. alata was 
carried out by Ulubelen and collaborators (1982), who 
identified the flavonoids C-glycosides 2”-
xilosylvitexin, vitexin, isovitexin and orientin. More 
recently, Brazilian researchers have investigated the 
phytochemistry and pharmacology of P. alata leaves 
(Pereira, et al. 2000, 2005; Petry et al. 2001; Amaral et 
al., 2001; Reginatto et al., 2001, 2004, 2006; De Paris 
et al., 2001; Birk et al., 2005; Rudnicki et al., 2007a, 
b; Vargas et al., 2007, Barbosa et al., 2008). A study 
sought to examine herb use among Hispanic females 
with Type II diabetes enrolled in two Community 
Health Centers in the Southwest USA reported the use 
of P alata (Johnson et al., 2006). 
Despite several studies, the active substances 
responsible for the anxiolytic and sedative effects 
attributed to passifloras have not been defined. In 
2004, two works using analytical methods to quantify 
substances in passifloras were reported. The first of 
these studies used HPTLC and HPLC methods to 
quantify flavonoids (Pereira et al., 2004). In the 
second, Reginatto et al., 2004 presented the 
quantification of a saponin extracted from leaves of P. 
alata (quadranguloside) by HPLC-UV. Early in the 
following year, Müller et al., 2005 used an HPLC-UV 
method to detect flavonoids present in P. alata 
medicinal extracts and leaves.  
Only two Brazilian studies, Runha et al., 2001 
and Oliveira et al., 2006, have examined the 
technological processes involved in the production of 
dry extracts of this native medicinal plant. 
The original review of P. edulis and P. alata 
was published almost ten years ago by Pereira and 
Vilegas (2000). In 2004, Dhawan and collaborators 
described the prominent species of the genus 
Passiflora and briefly discussed the species P. alata. 
In another review, the composition, efficacy and safety 
of P. edulis was reported (Zibadi and Watson, 2004). 
More recently, a review was published on 
morphology, phytochemistry and pharmacological 
aspects from Passiflora incarnata Linn (Patel et al., 
2009). A bibliographic review of passion fruit (P. 
edulis and P. alata) as a functional food, with 
emphasis on the fruit was reported by Zeraik et al. 
(2010). Considering the number of recently published 
papers, it is important to provide a current and 
systematic review of the scientific literature focused 
on P. alata leaves (Oliveira et al., 2007). 
 
2. PHARMACOBOTANICAL DESCRIPTION 
“Maracujá doce’ complies with the requirements of 
the Brazilian Pharmacopoeia (Brasil, 2010) and 
consists of the dried leaves of Passiflora alata Curtis. 
This plant is one of several Brazilian species of 
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Passifloraceae with edible fruits. Its ellipsoid fruit 
turns orange when ripe, has aromatic scent and sweet 
taste. Its leaves are bitter and the odour is 
characteristic. 
This Pharmacopoeia provides the diagnostic 
value of individual characters at the species level. Its 
leaves are simple, petiolate, glabrous, subcoriaceous, 
broadly ovate to oblong, 7-20 cm long and 4-15 cm 
wide. The base is rounded to slightly reentrant, apex 
acuminate and margin entire, smooth or somewhat 
undulate. The adaxial surface is brownish-green and 
the abaxial surface paler. The venation pinnate is more 
obvious on abaxial surface. The petiole 2-7 cm long is 
deeply channeled, having one or usually two pairs of 
extrafloral nectaries. Tendrils occur in the axils of the 
leaves.  
The preliminary anatomical study of its leaves 
shows common characters of Passiflora: hypostomatic 
leaves; dorsiventral mesophyll, collateral bundles and 
clusters of calcium oxalate. The epidermis is 
uniseriate. In frontal view it has polygonal cells with 
straight or slightly sinuous anticlinal walls, smooth 
cuticle and usually anomocytic stomata. The 
mesophyll is composed of one to three layers of 
palisade parenchyma and several layers of spongy 
parenchyma. Clusters of calcium oxalate occur in 
parenchyma and in the region of the ribs. In the 
transverse section through midrib, the adaxial surface 
presents convexity and the abaxial surface is obtusely 
angled. Subjacent to both surfaces, several layers of 
collenchyma are observed. The midvein is a broad arc 
and may be bounded adaxially and abaxially by fiber 
layers. The petiole is convex at abaxial and depressed 
at adaxial surface with two lateral projections. 
Collenchyma occurs at least in the adaxial and abaxial 
subepidermal positions. The vascular system in arc is 
surrounded by a sclerenchymatous sheat. Clusters of 
calcium oxalate of varying sizes may be found in 
mesophyll and midrib ground tissue. 
 
3. PHYTO-CONSTITUENTS 
The chemical composition of P. alata presents some 
divergence. A study to determine the chemical 
composition of medicinal plants made use of high-
speed extraction and HPLC for fingerprinting. The C-
flavonoid glycosides schaftoside, isoschaftoside, 
isoorientin, orientin, isovitexin and vitexin were 
chosen as analytical standards and their overall 
prevalence in all samples was determined. In P. alata, 
the marker flavonoids could not be detected in percent 
concentrations. Only traces of vitexin were observed 
in the P. alata.  The other tested flavonoids, including 
orientin and swertisin (P. incarnata markers), 
hyperoside, rutin, hesperidin and clorogenic acid were 
absent (Müller et al., 2005). In another study in which 
compounds were analysed by TLC, the vitexin band 
was not identified; a blue band indicated the presence 
of phenolic carboxylic acids such as caffeic acid 
(Pereira et al., 2004). Flavonoids are the main 
constituents, and are ussualy used as biomarkers (Petry 
et al., 1998). The main constituents are shown in Table 
I; flavonoids and saponins are reported to be the major 
compounds found in P alata.  
 
Table I. The main constituents present in Passiflora alata 
 
Phyto-constituents References 
Flavonoids  
2”-xylosylvitexin (1) Ulubelen, 1982 
Vitexin (2) Ulubelen, 1982, Pereira et al., 2005 
Isovitexin (3) 
Ulubelen, 1982, Müller et al., 2005, Pereira et al., 
2005 
Orientin (4) Ulubelen, 1982 
Rutin (5) Freitas, 1985; Oga et al.,1984; Moraes et al., 1997 
Vitexin-2’’-O-rhamnoside (6) Pereira et al., 2004 
Steroid glycoside  
3-O-β-D-glucopyranosyl-stigmasterol (7) Reginatto et al., 2001 
Triterpene saponins  
3-O-β-D-glucopyranosyl-oleanolic acid (8) Reginatto et al., 2001 
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3-O-β-D-glucopyranosyl-(1→3)-β-D-
glucopyranosyl-oleanolic acid (9) 
Reginatto et al., 2001 
3-O-β-D-glucopyranosyl-(1→2)-β-D-
glucopyranosyl-oleanolic acid (10) 
Reginatto et al., 2001 
9,19-cyclolanost-24Z-en-3β,21,26-
trihydroxy-3,26-di-O-gentiobiose 
(quadranguloside). (11) 
Reginatto et al., 2001 
Alkaloids  
Harman (12) Freitas, 1985; Machado et al., 2010. 
 
 
Figure 1  
Chemical structure of the main constituents present in Passiflora alata Curtis 
 
2”-xylosylvitexin (1) 
 
Vitexin (2) 
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Isovitexin (3) 
 
 
 
Orientin (4) 
 
 
 
Glu = ß-D-glucopyranosyl 
 
Rutin (5) 
 
Rha = α-L-rhamnopiranosyl 
Glu-Rha = glucose-rhamnose 
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Vitexin-2’’-O-rhamnoside (6) 
 
3-O--D-glucopyranosyl-stigmasterol (7) 
 
 
 
3-O--D-glucopyranosyl-oleanolic acid (8) 
3-O--D-glucopyranosyl-(13)- -D-glucopyranosyl-oleanolic acid (9) 
3-O--D- glucopyranosyl-(12)- -D-glucopyranosyl-oleanolic acid (10) 
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9,19-cyclolanost-24Z-en-3,21,26-trihydroxy-3,26-di-O-gentiobiose (11) 
 
 
Harmane (12) 
 
 
 
 
 
 
 
 
 
 
 
 
4. ANALYTICAL METHODS 
The use of thin-layer chromatography (TLC) for the 
purpose of identification of chemical constituents is 
described in Table II. Analytical reports using 
spectrophotometry to quantify compounds are 
displayed in Table III. Table IV summarizes the 
results obtained from high performance liquid 
chromatography (HPLC) methods. 
 
 
Table II.  Analysis of Passiflora alata by TLC 
 
Author/year Reference Substances Method specifications 
  Plates Mobile phase Visualization  
Petry et al., 
2001 
Flavonoids 
Vitexin 
Isovitexin 
Orientin 
Isoorientin 
Aluminum 
GF254  
Flavonoids 
Ethyl 
acetate:formic 
acid:acetic 
acid:water 
Methanolic solution 
diphenilboriloxiethylami
ne (0.5%) and PEG200 
(30% p/v). 
105C. 
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Chrysin 
 
 
Triterpenoids 
(80:1:8:10) v/v. 
 
 
Triterpenoids 
Short and long-wave UV 
light. 
Reginatto et al., 
2001 
Steroid glycoside and four 
triterpene saponins 
(quadranguloside). 
Aluminium 
GF254  
 
CHCl3:EtOH:AcO
H (60:40:6) v/v. 
Anisaldehyde H2SO4. 
100C 
 
De Paris et al., 
2002 
Flavonoids 
Vitexin 
Isovitexin 
Orientin 
Isoorientin 
Chrysin 
Petry et al. 
2001. 
 
Petry et al. 2001. 
 
 
Petry et al. 2001. 
 
Birk et al., 
2005  
Vitexin 
3-O-β-D-
glucopyranosyl(13)--D 
glucopyranosyl-oleanolic acid  
Quadranguloside 
Aluminium 
GF254  
 
Flavonoids 
AcOEt: 
acetone:AcOH:H2O 
(60:20:10:10, v/v) 
Saponins: 
CHCl3:EtOH:AcO
H (60:40:5, v/v) 
Flavonoids 
Methanolic solution 
diphenilboriloxiethylami
ne (0.5%) and PEG400 
(5% p/v) 
Anisaldehyde H2SO4. 
100C 
Saponins: 
Anisaldehyde H2SO4. 
100C 
UV366. 
 
Reginatto et al., 
2006 
Present only two major spots 
with chromatographic profile 
of flavonoids (one yellow and 
another one orange) 
Birk et al., 2005 Birk et al., 2005 
 
Birk et al., 2005 
 
According to the authors, the flavonoid composition of 
a P. alata extract was simpler than an extract of P. 
edulis. In the P. alata extract, three spots were 
detected by TLC that had characteristic flavonoid 
color. Saponins were observed exclusively in P. alata 
(De Paris et al., 2001). The P. alata extract presented 
two spots with characteristic flavonoid color; however, 
their RF values were not the same as any flavonoid 
used as a reference substance (Birk et al., 2005). In P. 
alata, only two major spots were observed; these 
major compounds showed chromatographic profiles of 
flavonoids (one yellow and another one orange) and 
saponins. In P. edulis, the C-glycosides vitexin and 
orientin were identified (Reginatto et al., 2006). 
 
Table III 
Analysis of Passiflora alata by Spectrophotometry 
 
Author/ 
Year 
Reference 
Substances 
Tested 
Method specifications  
Evaluation  References Results 
 
Petry et al., 
2001 
Flavonoids  
Apigenin 
UV absorption of the 
AlCl3–flavonoid 
complex. Detection 
392 nm. HP 5820 
spectrophotometer. 
Schmidt and 
González Ortega 
(1993) and Petry et 
a.l (1999). 
 
Content of flavonoids of 
P.edulis twice P. alata 
(4.60 vs. 2.90 p/p). 
De Paris et 
al., 2002 
Flavonoids  
Apigenin 
UV absorption of the 
AlCl3-flavonoid 
complex. HP 5820 
spectrophotometer. 
 
Petry et al., 2001. 
 
Content of flavonoids of 
P.edulis: (4.04%) P. alata 
(1.90%). λmax at 278, 300, 
400 nm. 
Müller et 
al.,2005 
Flavonoids  
Helvetica 
UV–vis double array 
spectrophotometer 
Passiflora incarnata 
monograph 
Helvetica Pharm.: within 
the limits predetermined 
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 Pharm.: 
Hyperoside 
British Pharm.: 
Vitexin 
SHIMADZU UV-601. (Pharmacopoeia 
Helvetica and British 
Pharmacopoeias) 
for P. incarnata (0.3%). 
British Pharm.: Under the 
lower limit, with total 
flavonoid value of 0.55g% 
Reginatto 
et al.2006 
According to 
Petry, 2001 
 
According to Petry et 
al, 2001 
 
 
Petry et al., 2001 
 
Total flavonoid content; 
2.9 % P. alata 4.0 % P. 
edulis. 
Barbosa et 
al., 2008 
Apigenin Ultraviolet 
Absorption of the 
AlCl3-flavonoid 
complex. 
 λmax: 398 nm. 
Flavonoids content: 2.1% 
for P. alata and 3.9% for 
P. edulis. 
Chabariberi 
et al., 2008 
Rutin Theoretical λmáx = 394 
nm (French. Pharm.) 
and 401 nm (European 
Pharm.). 
Passiflora incarnata 
(Modification of the 
procedures from 
French and European 
Pharmacopoeias) 
Practical λmáx = 427 nm 
(French. Pharm.) and 430 
nm (European Pharm.). 
 
An approach comprising accelerated solvent 
extraction followed by quantitative HPLC analysis 
was adopted in fingerprinting 115 samples of different 
species of Passiflora. In P. alata was detected a 
common unidentified peak eluting at 40.0 min. Such a 
peak had characteristic UV absorbance maxima at 267 
and 337 nm suggesting a closely related analog of the 
chosen markers studied: schaftoside/isoschaftoside, 
isoorientin, orientin, isovitexin and vitexin 
(Abourashed et al., 2002). 
Pesticide residue is generally unacceptable in 
medicinal plants and the literature shows analytical 
methods to determine it. Da Silva and collaborators 
(2007) achieved promising results using a 
simultaneous optimization strategy based on neuro-
genetic approach applied to a HS-SPME-GC-ECD 
(Headspace Solid Phase Microextraction coupled to 
Gas Chromatography with Electron Capture 
Detection) method for simultaneous determination of 
the pesticides chlorotalonil, methyl parathion, 
malathion, α-endosulfan and β-endosulfan in herbal 
infusions of P. alata. 
 
5. PHARMACOLOGY AND TOXICITY 
The first report describing the pharmacological 
activity of P. alata came from Oga and collaborators 
in Brazil in 1984. They found that an extract made 
from P. alata leaves increased the induction of sleep 
by pentobarbital in rats. It also increased the latency 
time caused by the pentylenetetrazole-induced seizures 
and decreased spontaneous motor activity when 
administered by the intraperitoneal route at 75 and 150 
mg/kg. They found an LD50 value of 456 mg/kg for the 
extract (Oga et al., 1984). 
Another study compared the pharmacological 
activity of hydroethanol extracts of P. alata and P. 
edulis leaves. The anxiolytic activity was evaluated 
using the elevated plus-maze test, and the chemical 
composition of hydroethanol extracts of P. alata and 
P. edulis leaves was determined. Diazepam (1 mg/kg) 
was used as a standard anxiolytic drug. All groups 
tested were compared with saline. The extracts 
presented anxiolytic activity in dosages around 50, 100 
and 150 mg/kg. With respect to the phytochemical 
analysis, the hydroethanol extracts of P. edulis leaves 
presented almost twice the flavonoid content than P. 
alata (Petry et al., 2001). 
In 2001, De Paris carried out a similar study 
using aqueous extracts instead of hydroethanol 
extracts. Once again, the phytochemical results 
showed that aqueous extracts of P. edulis leaves 
presented twice the flavonoid content of P. alata. By 
comparing these results with those of the previous 
study, the authors determined that the solvent (ethanol 
40 °GL or water) did not qualitatively change the 
chemical composition with respect to flavonoids and 
saponins and, moreover, aqueous and hydroethanol 
extracts had identical anxiolytic effects. The 
intraperitoneal administration of P. alata at doses of 
100 and 150 mg/kg and of P. edulis at doses of 50, 100 
and 150 mg/kg showed anxiolytic effects according to 
the elevated plus-maze model (De Paris et al., 2001). 
In 2006, Reginatto et al. compared the 
potential anxiolytic activities of two Passiflora spray-
dried powders obtained from P. alata and P. edulis by 
oral administration. The activity profiles of the 
extracts were the same as those previously reported for 
freeze-dried extracts of P. alata and P. edulis 
administered intraperitoneally (Petry et al., 2001; De 
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Paris et al., 2001). Similar to diazepam, animals 
treated with spray-dried extracts of P. alata (800 
mg/kg) and P. edulis (400 and 800 mg/kg) showed an 
anxiolytic effect demonstrated by a significant 
increase in the number of entries and permanency in 
open arms (p <0.05), as well as a decrease in the time 
spent in closed arms (p <0.05). 
 
 
 
 
Table IV 
Analysis of Passiflora alata by High Performance Liquid Chromatography (HPLC) 
Author/year 
 
Scope Column Detection Elution Results 
De Paris et 
al., 2002 
 
 
Qualitative analysis 
of flavonoids: 
Vitexin, Isovitexin 
Orientin, Isoorientin 
Chrysin. 
NovaPack RPC18 
(3.9 x 150 mm i.d., 
4 μm) 
Ultraviolet detector 
(Waters, model 486), 
integrator (Waters 746). 
Peak identification 
photodiode-array detector 
(Waters PDA 996), 
performed at 340 nm. 
Acetonitrile: Phosphoric 
acid 0.05% (20:80, 
m/m), flow rate of 0.8 
ml/min. at 21± 2 °C 
P. alata 5 substances with 
retention time (RT) 
different from the 
reference substances. 
Müller et al., 
2005 
 
 
Qualitative analysis 
of flavonoids: 
Orientin, Swertisin 
Vitexin, Hiperoside 
Rutin, Hesperidin 
and Clorogenic acid. 
Luna RPC18 (5um) 
Phenomenex 
Photodiode array detector. Isocratic elution (CAN–
H2O–HOAc 18:82:0.5) 
with a 1 mL/min flow.  
Isovitexin was 
determined by external 
standard method, 
gradient elution mode* 
P. alata: traces of vitexin 
and isovitexin. 
 
Not found: orientin, 
swertisin, rutin. 
Pereira et al., 
2004, 2005 
Quantitative analysis 
of total flavonoids: 
Rutin, vitexin, 
isoorientin and 
orientin. Validation 
of analytical 
procedures. 
Supelco RP18 
column (250 x 4.0 
mm i.d.; 
5 m) 
Photodiode array detector 
at 337 nm for detection. 
solvent A [2.0% formic 
acid (99%;) in water] 
and solvent B [HPLC 
grade acetonitrile]** 
flow-rate was 0.8 
mL/min. 35°C. 
Total flavonoid content 
showed no significant 
statistical difference. 
Reginatto et 
al., 2004, 
2006 
Quantification of 
saponin 
quadranguloside. 
Validation of 
analytical 
procedures. 
Waters Nova-Pack 
Phenyl column (150 
x 3.9 mm i.d.; 4 
m) 
Detection was at 205 nm 
and 0.1 AUFS 
Acetonitrile : 0.1% 
aqueous phosphoric acid 
(29:71, v/v), flow rate of 
1.0 mL/min. Room 
temperature (222°C) 
Content of 
quadranguloside: 
22.2%(w/w), 
corresponding to 0.8% 
(w/w) in relation to the 
dried leaf samples. 
 
*Isovitexin was determined in plant material according to an external standard that was diluted (MeOH 50%) to 4.0, 8.0, 
12.0, 16.0 and 20.0 μg/mL. Standard concentrations were produced in triplicate. A gradient elution mode with a 1 
mL/min flow was employed: 1–20 min 10% solvent B (MeOH) and C (ACN) in A (H2O–HOAc, 100:0.5, pH 2.88), 20–
30 min 15% B and C in A, 30–35 min 20% B and C in A. (Müller et al., 2005) 
 
** The separation was performed using gradient elution: 0–10 min 15% B in A, 10–40 min 15–30% B in A and 40–50 
min 30–15% B in A. 
 
P. alata extract was administrated orally in 
rats at dose of 1000 mg/kg and it was observed an 
increase in high-density lipoprotein level (HDL-
cholesterol) (Doyama et al., 2005). More recently, 
Rudnicki et al., (2007a, 2007b) studied the antioxidant 
and hepatoprotective activities of P. alata. In the first 
trial (Rudnicki, 2007a), the antioxidant activity was 
determined  by  in  vivo  (Total  Reactive  Antioxidant  
 
 
Potential) and ex vivo (in rat liver slices) assays. Their 
results showed a high level of activity (DE50 = 171 
mcg/mg), and they related the activity to the total 
phenolic compounds. In a second trial (Rudnicki, 
2007b), they showed a hepatoprotective effect of P.  
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alata on carbon tetrachloride induced oxidative 
damage in rats. The extract reduced the levels of 
markers of liver failure (ALT, AST) and 
histopathological changes in the samples. Other study 
showed significant antioxidante activity of P. alata 
and P. edulis on stimulated neutrophils (Zeraik et al., 
2011). 
In another study, the antiulcer activity of P. 
alata was evaluated, doses of 100, 200 e 400mg/kg of 
extracts were tested in the same conditions with HCl 
150 mmol/L versus lanoprazole. P. alata showed 
100% of protection in total lesion area (TLA) at the 
three concentrations studied, while lansoprazole 
showed 75% of protection (Wasicky, 2007). 
Studies evaluating the pharmacological 
activities of P. alata showed interesting results, 
demonstrating anticonvulsant and anxiolytic activities 
(Romanini et al., 2006; Provensi et al., 2008; Quintans 
Junior et al., 2008; Sousa et al., 2008). Some studies 
have been made in order to evaluate toxicity of 
Passiflora extracts (Boeira et al., 2010; Amaral et al., 
2001), and all of them showed no toxic effects in dose 
up to 4800 mg/kg into a single dose, or 300 mg/kg for 
14 days. However, the researchers found some DNA 
damage in dose dependent-manner, after 72 hours of 
treatment (Boeira et al., 2010). Also, Giavina-Bianchi 
and co-workers, in 1997, presented a case-report of P. 
alata’s and Rhamnus purshiana’s induced respiratory 
allergic disease. They conducted a skin testing and a 
Western blot and confirmed the sensitization of the 
patient to these plant extracts, confirming new 
etiologic agents of IgE-mediates occupational asthma 
and rhinitis (Giavina-Bianchi et al, 1997).  
 
6. PHYTOPHARMACEUTICAL TECHNOLOGY 
A study by Runha and collaborators (2001) was 
conducted in order to develop processes for the 
production of dry extracts of medicinal Brazilian 
plants using spouted beds as drying equipment. 
Passion flowers were used as a model plant. The main 
conclusion of this work was that an increase in the 
drying temperature, together with a low feed flow rate 
of hydro-alcoholic extracts, tended to increase the 
degradation of flavonoid compounds. 
The performance of the spray and spouted-bed 
dryer and the physicochemical properties of the 
products resulting from drying the hydro-alcoholic 
extracts of the three plants P. alata, Bauhinia 
forficata, and Maytenus ilicifolia were evaluated 
comparatively by Oliveira et al., 2006. 
Recently, Bott et al., (2010) carried out a 
stability study of spray- and spouted bed-dried extracts 
of P. alata under stress storage conditions that 
suggested the degradation of marker substance 
(vitexin) and their short shelf lives due to the high 
hygroscopicy of the extracts. 
 
7. HORTICULTURAL ASPECTS 
Sweet passion fruit (P. alata) is gaining importance in 
the in natura fruit market due to its differential value. 
Genetic breeding is crucial to improve crop quality 
and productivity. In order to evaluate some physical 
characteristics and the nutrient distribution in sweet 
passion fruit a study was carried out by Vasconcellos 
et al. (2001). The pollination biology of P. alata was 
studied in south-eastern Brazil, specifically the 
importance of chemical features of floral nectar, 
pigments and odours. Bees are the pollinators required 
by P. alata to produce fruits (Varassin et al., 2001). 
Fourteen horticultural characteristics of five sweet 
passion fruit (P. alata) populations were evaluated, 
and a considerably high variability among plants and 
low among populations was observed for these 
characters by Martins et al. (2003). The geographical 
distribution, ecological characteristics, flowering and 
fruiting times, and pollinating agents of P. alata were 
considered and related to molecular genetic data 
gathered simultaneously by Koehler-Santos et al., 
(2006a, 2006b). The best treatment to enhance the 
growth of sweet passion fruit (P. alata) seedlings was 
evaluated by various authors (Veras et al., 2000; 
Leonel and Pedroso, 2005, Ferreira et al., 2005; 
Freitas et al., 2006; Freitas et al., 2008; Roncatto et al, 
2008). Damatto and collaborators (2005) evaluated the 
influence of organic fertilizers for production of P. 
alata and verified better quality and larger production 
of fruits. Another study performed by Lima et al. 
(2006) verifed the germination and speed of 
emergence index of passion fruit species to obtain 
plants suitable for grafting. The genetic variability of 
17 sweet passion fruit accesses, using RAPD 
molecular markers was studied by Bellon et al. (2009). 
The environmental conditions influence on storage of 
sweet passion-fruit (P. alata) seeds was studied, after 
twelve months, seeds with humidity close to 10% and 
conditioned in plastic bags showed better 
conservation, when maintained at 10ºC (Osipi and 
Nakagawa, 2005). 
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8. LEGAL ISSUES 
The use of P. alata was officially recognized in the 
first edition of Brazilian Pharmacopoeia (Silva, 1929) 
where it was described as “Maracujá”: Passiflora 
alata Aiton. The treatments described are in the form 
of fluid extracts and tinctures of its leaves. In the 
second edition (Farm. Bras. II, 1959), the fluid extract 
was deleted. In the third edition (FBRAS., 1977) 
analytical methods for the quantification of flavonoids 
and alkaloids in the plant were included. More 
recently, P. alata Curtis was cited in the fifth edition 
(Brasil, 2010).  
The Resolution RE Nº 89, dated March 16 
2004 (Brasil, 2004), resulted in publication of the "List 
of Simplified Registration Procedures for Herbal 
Products" on sale as “over the counter” drugs, 
tinctures and extracts prepared from the leaves of 
sweet passion fruit. In this case, the referenced plant 
was P. incarnata and not P. alata (Brazilian species), 
and it was indicated as a sedative. This resolution was 
published in the Official Executive Gazette on March 
18 2004 with the issuing agency: ANVISA - National 
Agency for Sanitary Surveillance, which is valid for 
all of Brazil. 
In 2005, the “Technical Regulation of Plants 
for Tea Preparations” was published. It was officially 
recognized in the Collegiate Board Resolution - RDC 
Nº 267, dated September 22nd 2005, which includes 
four species of Passiflora, the Maracujá-açú (P. 
quadrangularis L.), the Maracujá-azedo (P. edulis f. 
flavicarpa Degener), Maracujá-doce (P. alata Dryand) 
and Maracujá-roxo (P. edulis Sims.) (Brasil, 2005). 
Resolution 89 was then repealed by the 
normative instruction n°5, dated December 11
th
 2008. 
The "List of Herbal Medicines Simplified 
Registration" was approved. P. incarnata was still 
featured, but was indicated as a mild anxiolytic and the 
entry was modified to include only vitexin as an 
expressed flavonoid. 
In February 2009, a list of 71 medicinal plants 
was proposed. This list was named RENISUS – the 
National List of Medicinal Plants of Interest for the 
Public Health System. The passion fruit monograph 
listed Passiflora spp., and it included P. alata, P. 
edulis and P. incarnata (Brasil, 2009). In 2010, the 
monographs of P. edulis and P. alata were approved 
in public consult for inclusion on fifth Brazilian 
Pharmacopoeia (Brasil, 2010). 
 
 
 
10. FINAL CONSIDERATIONS 
The Brazilian sweet passion fruit P. alata is a well-
known plant used in South American folk medicine. In 
Brazil, it is officially recognized as a phytomedicine, 
and it has been commercialized either alone or in 
association with other plants (Crataegus oxycanta, 
Salix alba, Erythryna mulungu) for treatment of 
anxiety disorders. Its pharmacological and 
phytochemical properties have been studied by many 
Brazilian groups. P. alata is a promising candidate as 
a phytotherapeutic drug due to its range of activities 
(antiinflammatory, antioxidant). However, there is 
controversy regarding its chemical composition and, 
even if a chemical characterization can be made, there 
are no proposed biomarkers for this species. Further 
studies are necessary to determine the phytochemical 
characteristics of P. alata and develop biomarkers 
assays. Such studies will reveal any correlation 
between chemical composition and pharmacological 
activity and allow for distinction between dose-
dependent and independent activities.  
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